Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 0 | 0 | 0 | 0 |
Cost of revenue | — | — | — | — |
Gross profit | — | — | — | — |
Operating expense | ||||
Research & development | 687K | 825K | 708K | 603K |
Selling general and admin | 435K | 546K | 343K | 465K |
Other operating expenses | — | — | — | — |
Operating income | -1.1M | -1.4M | -1.1M | -1.1M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 645K | 848K | 822K | 736K |
Other income expense | -3.2M | 2.7M | -3.1M | -2.7M |
Pretax income | -5.0M | 473K | -4.9M | -4.5M |
Tax provision | 3K | 6K | 3K | 2K |
Net income | -5.0M | 467K | -4.9M | -4.5M |
Basic EPS | 0.0 | — | 0.0 | 0.0 |
Diluted EPS | 0.0 | — | 0.0 | 0.0 |
Basic average shares | 282.8M | — | 277.2M | 275.1M |
Diluted average shares | 282.8M | — | 277.2M | 275.1M |
EBITDA | -1.0M | -1.2M | -962K | -999K |
Net income from continuing op. | -5.0M | 467K | -4.9M | -4.5M |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |